Alzheimer disease: open trials in Argentina

17 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Buenos Aires · Instituto Privado Kremer, Córdoba · CEN Centro Especializado en Neurociencias, Córdoba · Centro Médico Luquez, Córdoba · La Plata · Mar del Plata · Fundacion Estudios Clinicos, Rosario
Registry updated 2026-11-06
NCT07717411
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Italiano de Buenos Aires, Buenos Aires · INECO Neurociencias Oroño, Rosario
Registry updated 2026-11-06
NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM), Buenos Aires · Hospital Italiano de Buenos Aires (HIBA), Buenos Aires · Centro Neurobiológico y de Estrés Traumático - CENydET S.R.L., Ciudad Autonoma de Buenos Aires · Sanatorio Morra S.A., Córdoba · Instituto Médico DAMIC, Córdoba · Instituto Modelo de Neurología, Fundación Lennox, Córdoba · Resolution Psychopharmacology Research Institute, Mendoza
Registry updated 2026-11-03
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Organización Médica de Investigación, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Buenos Aires · Centro Neurobiológico y de Estrés Traumático - CENydET S.R.L., Ciudad Autonoma de Buenos Aires · Fundación para el Estudio y Tratamiento de Enfermedades mentales- FETEM, Ciudad Autónoma de Buenos Aires · CINME S.A. - Centro de Investigaciones Metabólicas - Viamonte 2213/2215, Ciudad Autónoma de Buenos Aires · Instituto Privado Kremer, Córdoba · Centro Especializado en Neurociencias - CEN, Córdoba · Instituto Médico de la Fundación Estudios Clínicos, Rosario
Registry updated 2026-10-27
NCT06976216
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM), Buenos Aires · Buenos Aires · Sanatorio Morra S.A., Córdoba · Instituto Kremer, Córdoba · Fundación Lennox - Instituto Modelo de Neurología, Córdoba
Registry updated 2026-10-27
NCT07033494
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) (Site 0400), Caba · Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) (Site 0404), Ciudad de Buenos Aires · Organizacion Medica de Investigacion (Site 0401), Ciudad de Buenos Aires
Registry updated 2026-10-20
NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Italiano de Buenos Aires, Buenos Aires · INECO, Buenos Aires · CIER, C. A. B. A. · Fundacion Scherbovsky, Mendoza · INECO Neurociencias Oroño, Rosario · Sanatorio del Sur S.A., San Miguel de Tucumán
Registry updated 2026-10-19
NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Buenos Aires · Organización Médica de Investigación, Buenos Aires · Buenos Aires · Ciudad Autónoma de Buenos Aires · Ciudad Autónoma de Buenos Aires · Ciudad Autónoma de Buenos Aires · Córdoba · Córdoba · Rosario
Registry updated 2026-10-16
NCT06937229
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Buenos Aires · Buenos Aires · Buenos Aires · Ciudad Autonoma de Buenos Aires · Córdoba · Córdoba · Córdoba · Córdoba · Córdoba · Córdoba · La Plata · Mar del Plata · Mendoza · Rosario
Registry updated 2026-10-16
NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital Italiano de Buenos Aires, ABB · Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Buenos Aires · CEN Centro Especializado en Neurociencias, Córdoba · Centro Médico Luquez, Córdoba · Instituto Médico DAMIC, Córdoba · Resolution Psychopharmacology Research Institute, Mendoza
Registry updated 2026-10-08
NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Trial Treatment · Phase 2 · Celgene
Buenos Aires · Ciudad Autónoma de Buenos Aires · Córdoba · Córdoba · Mar del Plata · Mendoza · Santiago del Estero
Registry updated 2026-10-06
NCT00869817
Dominantly Inherited Alzheimer Network (DIAN)
Research · Washington University School of Medicine
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa, Buenos Aires · Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI), Salta
Registry updated 2026-10-05
NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Caba · Córdoba
Registry updated 2026-09-30
NCT05552157
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Trial Treatment · Phase 2/3 · Washington University School of Medicine
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI, Ciudad Autonoma de Buenos Aire
Registry updated 2026-07-27
NCT06647498
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Trial Treatment · Phase 2/3 · Washington University School of Medicine
Instituto de Investigaciones Neurologicas Raul Carrea, FLENI, Ciudad Autonoma de Buenos Aire
Registry updated 2026-07-27
NCT06611878
Memory for Music: Individual Intensive Musical Training in Alzheimer's Disease
Trial Treatment · NORCE Norwegian Research Centre AS
Universidad de Ciencias Empresariales y Sociales, Buenos Aires
Registry updated 2026-05-08
NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
Trial Treatment · Phase 2 · GlaxoSmithKline
Buenos Aires · Ciudad Autonoma de Bueno · Ciudad Autonoma de Buenos Aire
Registry updated 2026-02-02

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error